InvestorsHub Logo
Followers 138
Posts 23060
Boards Moderated 0
Alias Born 04/08/2004

Re: None

Saturday, 12/02/2023 10:08:36 AM

Saturday, December 02, 2023 10:08:36 AM

Post# of 460652
Reserve your judgment of Dr. Christopher Missling MS PhD MBA until after you wee and read the upcoming article regarding the Phase 2b/3 trial using blarcamesine to treat Alzheimer's disease.

GOD bless,
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News